Ticker Details
Replimune Group, Inc.
IPO Date:	July 16, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$405.43M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 3.34%
Avg Daily Range (30 D):	$0.30 | 9.42%
Avg Daily Range (90 D):	$0.30 | 5.79%

Institutional Daily Volume
Avg Daily Volume:	.97M
Avg Daily Volume (30 D):	9.72M
Avg Daily Volume (90 D):	4.32M

Trade Size
Avg Trade Size (Sh.):	113
Avg Trade Size (Sh.) (30 D):	228
Avg Trade Size (Sh.) (90 D):	163

Institutional Trades
Total Institutional Trades:	2,395
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$1.09M
Avg Institutional Trade (90 D):	$1.25M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.76M
Avg Closing Trade (30 D):	$1.21M
Avg Closing Trade (90 D):	$1.31M
Avg Closing Volume:	135.84K

News

May 18, 2026 @ 1:49 AM REPL Investors Have Opportunity to Join Replimune ... Source: Schall Law Firm

Apr 21, 2026 @ 8:14 AM Oncolytic Virus Immunotherapy Market Landscape Rep... Source: Researchandmarkets.Com

Apr 10, 2026 @ 9:02 PM Replimune Receives Complete Response Letter from t... Source: Replimune Group, Inc.

Jan 23, 2026 @ 10:52 AM Oncolytic Virotherapy Market - Global Industry Siz... Source: Researchandmarkets.Com

Nov 7, 2025 @ 9:45 PM Replimune Presents Late-Breaking Abstract and Addi... Source: Replimune Group, Inc.

Financials
	TTM	Q3 2026	Q2 2026
Basic EPS	$-3.44	$-.77	$-.9
Diluted EPS	$-3.44	$-.77	$-.9
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-314.85M	$-70.93M	$-83.1M
Operating Income / Loss	$-325.91M	$-71.87M	$-84.29M
Cost of Revenue
Net Cash Flow	$-49.29M	$20.65M	$4.92M
PE Ratio

Splits
Dec 01, 2010	15:1